Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record, with a small difference in title or year; 46 of the 46 references it cites were found in a registry or an index.

Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus

Open access

Abstract

BACKGROUND: Previous research has suggested that thiazide diuretics and beta-blockers may promote the development of type 2 diabetes mellitus. However, the results of previous studies have been inconsistent, and many studies have been limited by inadequate data on outcomes and by potential confounding. METHODS: We conducted a prospective study of 12,550 adults 45 to 64 years old who did not have diabetes. An extensive health evaluation conducted at base line included assessment of medication use and measurement of blood pressure with a random-zero sphygmomanometer. The incidence of new cases of diabetes was assessed after three years and after six years by measurement of serum glucose concentrations while the subjects were fasting. RESULTS: After simultaneous adjustment for age, sex, race, education, adiposity, family history with respect to diabetes, physical-activity level, other health-related behavior, and coexisting illnesses, subjects with hypertension who were taking thiazide diuretics were not at greater risk for the subsequent development of diabetes than were subjects with hypertension who were not receiving any antihypertensive therapy (relative hazard, 0.91; 95 percent confidence interval, 0.73 to 1.13). Likewise, subjects who were taking angiotensin-converting-enzyme inhibitors and calcium-channel antagonists were not at greater risk than those not taking any medication. In contrast, subjects with hypertension who were taking beta-blockers had a 28 percent higher risk of subsequent diabetes (relative hazard, 1.28; 95 percent confidence interval, 1.04 to 1.57). CONCLUSIONS: Concern about the risk of diabetes should not discourage physicians from prescribing thiazide diuretics to nondiabetic adults who have hypertension. The use of beta-blockers appears to increase the risk of diabetes, but this adverse effect must be weighed against the proven benefits of beta-blockers in reducing the risk of cardiovascular events.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm200003303421301

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 4

  1. 1981, Lancet, 2, 539
  2. Mykkanen L, 1994, J Hypertens, 12, 1425
  3. Samuelsson O, 1994, J Hum Hypertens, 8, 257
  4. Chiang CL. Standard error of the age-adjusted death rate. Vital statistics — special reports: selected studies. Vol. 47. No. 9. Washington, D.C.: Government Printing Office, August 1961.

Cited by

See all 1,202

Metadata

Authors
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L.
Affiliations
  • Johns Hopkins University (US)
  • University of Minnesota (US)
  • University of Mississippi Medical Center (US)
Venue
New England Journal of Medicine
Published
2000-03-30
Volume
342
Issue
13
Pages
905-912
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2334899541
Cited by
1,202
References
44
Citations by year
2026: 7 · 2025: 24 · 2024: 23 · 2023: 27 · 2022: 20 · 2021: 42 · 2020: 29 · 2019: 34 · 2018: 36 · 2017: 39 · 2016: 42 · 2015: 47 · 2014: 47 · 2013: 43 · 2012: 42
FWCI
44.74
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01hc55016-37-0-0, n01hc55018-38-0-1, n01hc55015-48-0-1)
  • National Heart, Lung, and Blood Institute (N01-HC-55018, ­N01-HC55016, N01‐HC‐55015)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
hypertension, type 2 diabetes, antihypertensive therapy, beta-blockers, thiazide diuretics, ACE inhibitors, calcium channel blockers, diabetes risk factors, drug-induced diabetes, diabetes incidence
MeSH terms
Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Benzothiadiazines, Calcium Channel Blockers, Diabetes Mellitus, Type 2, Diuretics, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Regression Analysis, Risk Factors, Incidence, Multivariate Analysis, Sodium Chloride Symporter Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1056/nejm200003303421301
The paper
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000). Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus. New England Journal of Medicine. https://doi.org/10.1056/nejm200003303421301

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.